• SRAX revenues grew 53 percent sequentially for Q2 2019
• The company changed its name as part of its new business strategy
• SRAX has partnered with Yash Birla Group, one of India’s largest conglomerates, to launch BIGtoken in India

Today, consumers are becoming more aware of the value of their data. They expect to keep data private and to get compensated for releasing their data. As a result, big social media platforms are experiencing significant consumer backlash. Moreover, privacy laws at both the state and federal levels are beginning to impact the way that marketers can reach consumers. These laws are putting the value and control of data back into the hands of the consumer.

SRAX Inc. (NASDAQ: SRAX) offers a platform called BIGtoken.com that allows consumers to own and monetize their data. SRAX claims to be building what will be the most valuable opted-in data set in the world. With over 16 million users worldwide, the company aims to prove that consumers are interested in their data and want to get compensated by marketers.

Users can sign in to the BIGtoken app to see exactly how much they have earned. Their earnings reflect the value of their data in U.S. currency and can be obtained one of two ways: users can enter an email address associated with their PayPal accounts and submit transactions for money to be deposited, or they can choose the gift card amounts that they’d like to receive from their favorite retailers and have digital gift cards sent to them via email. Earnings do not expire, so users can build up the value of their data with no pressure to use immediately.

The BIGtoken (blockchain identification graph) platform creates a secure and transparent environment for consumers to own, verify and sell their data. It provides consumers, marketers and developers with a comprehensive data-management solution that leads to consumer empowerment and compensation; data verification and authentication; and open-source governance and development.

Results for the three months ended June 30, 2019, reflect the power of this new technology and market approach. The company reported a 53 percent growth from Q1 2019 to Q2 (http://ibn.fm/23TFJ). Moreover, SRAX has become profitable within the last five years. “Share prices do not always rationally reflect the value of a business,” the report noted, as analysts suggest that SRAX shares appear to be rather undervalued.

SRAX management is responding to the pressure on share price. As part of a new business strategy, the company, formerly Social Reality Inc., has been rebranded to SRAX Inc., a change consistent with its evolution away from social media to consumer data management and technology.

“Changing our name to SRAX is symbolic of our shift to a broader strategy to answer the needs of today’s consumer,” SRAX CEO and Founder Christopher Miglino stated in a news release (http://ibn.fm/OhPWB). “While our roots were in social media, today we are focused on building the platform and tools to unlock the power of data. Through BIGtoken we put data back into the hands of consumers and through our verticals are delivering verified data to brands looking for a competitive edge.”

Recently, SRAX signed a joint venture with the Yash Birla Group to launch BIGtoken in India. The Yash Birla Group, based in Mumbai, is one of the country’s largest conglomerates, with diversified interests in consumer and industrial products (http://ibn.fm/nJImb).

SRAX also announced that users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data. Many dedicated users who have acted as community gurus, recruited new members or otherwise helped to develop the ecosystem can deposit their earnings directly into their PayPal accounts or be paid through gift cards from their favorite retailers, such as Walmart.

For more information, visit the company’s website at www.SRAX.com

• The direct-selling industry posted $192.9 billion in sales in 2018, marking the highest-ever total for the growing sector
• Sharing Services recorded a nine-fold increase in 2019 from its 2018 sales numbers
• SHRG continues its global expansion in an effort to take full advantage of the growing global market

Sharing Services Global Corporation (OTCQB: SHRG) had a record year, establishing itself as an impressive performer in an industry that is itself seeing record numbers. The direct-selling industry reached its highest sales ever – topping out at $192.9 billion in 2018 – with sales up in 65 percent of the direct-selling countries around the world. Sales aren’t the only indicators of the sector’s strong and steady performance. The industry’s global independent sales force reached 118.4 million, with more than 13.8 million individuals joining the ranks of direct-sales firms since 2015 alone (http://ibn.fm/zzy4u).

Sharing Services’ numbers also continue to grow. The company, which is dedicated to selling products directly to consumers, has posted record-breaking sales since its December 2017 release of a line of health and wellness products (http://ibn.fm/WtbDh). The company’s sales total of $85.9 million for its fiscal year ended April 30, 2019 (http://ibn.fm/4VG4J), represents a nine-fold increase, or a $77.5 million jump, from SHRG’s FY2018 sales of $8.4 million.

Sharing Services’ products are available through Elevacity Global LLC and Elepreneurs LLC, its two wholly owned subsidiaries, which are responsible for the manufacturing, distribution and sale of all products offered by the company’s international independent network of distributors.

Sharing Services is carving its niche in this booming market by differentiating itself from its competitors in a number of important ways. First, the company’s proprietary nutraceutical products contain ingredients that have been known to stimulate hormones that trigger happiness, such as dopamine, oxytocin, serotonin and endorphins. In addition, the company’s unique selling model is carefully designed to encourage expansion and rapid growth through a unique compensation structure.

Finally, Sharing Services has implemented its proven Blue Ocean Strategy throughout the company and its independent sales force. Highly successful, the Blue Ocean Strategy melds key components of the business together to implement the company’s mission. Those components include elevating SHRG’s passionate and dedicated Elepreneur sales force, utilizing the growing direct-selling channel to generate impressive organized growth and creating successful independent business leaders.

Headquartered in Plano, Texas, Sharing Services operates out of a 10,000-square-foot facility that is designed to house its executive staff, customer-service, operations and training rooms, as well as a video production suite.

With both national and worldwide numbers indicating impressive future possibilities in the direct selling industry, Sharing Services is starting its global expansion. These steps include announcing plans to market its Elevacity line of products in Canada, New Zealand and Australia, as well as expanding its Elepreneur opportunity elsewhere. The company is focused on leveraging its continued momentum and offerings on a global scale.

“We have aggressive plans to expand our markets rapidly and increase our revenues dramatically to bring profitability and shareholder value to this company,” Sharing Services CEO John “JT” Thatch stated in a news release (http://ibn.fm/yrI82).

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• SPRWF recorded revenues of approximately $19 million net of excise tax for Q4 2019, representing a jump of over 400 percent
• Supreme Cannabis forecasts net revenue for fiscal 2020 in the range of $150 million to $180 million
• The company recently closed on its acquisition of privately held Truverra for 14.7 million common shares

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently announced preliminary figures for the quarter ended June 30, 2019, and for its full fiscal year 2019 (http://ibn.fm/QVFZC). Preliminary figures show sales of $19 million net of excise tax for the three-month period. The company also anticipates reporting positive adjusted EBITDA on a consolidated basis for the 12-month period.

Supreme Cannabis’ figures are noteworthy when compared with others within the industry. Sales for the quarter are expected to have jumped more than 400 percent over fourth quarter 2018, when revenue was $3.55 million. Additionally, Supreme Cannabis expects net revenue in the range of $150 million to $180 million for fiscal year 2020, outpacing industry analysts’ expectations. Audited figures for Q4 2019 and the full year will be reported by Supreme Cannabis on September 17 after market close.

The company also expects to report positive adjusted EBITDA on aggregate for the year, positioning it as one of the few cannabis firms able to achieve this result. Based in Toronto, Canada, Supreme Cannabis is focusing on its strategy of pursuing opportunities and generating sustainable growth in what it sees as a global emerging cannabis market. It boasts industry-leading brands and international optionality.

“In a sector dominated by headlines, our measured approach to capital deployment and brand-building sets us apart,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We believe our preliminary results demonstrate the strength of our business during an inflection point within the industry, [signifying a] path toward profitability and continued disciplined growth.”

The continued success of Supreme Cannabis has been noted by industry spokespeople for some time. Bank of America Merrill Lynch initiated coverage of Supreme Cannabis in April with a ‘buy’ rating. Analyst Christopher Carey sent a note, calling the company an “underappreciated small cap” and praising its premium retail strategy and efficient delivery format (http://ibn.fm/AZAMf).

“Our company has taken deliberate steps to grow in a focused, responsible and compliant manner, building a strong core business and an authentic brand and then expanding into new lines of business and international markets,” Dhaliwal noted. “Looking forward, we remain focused on building our portfolio of premium consumer experience driven brands.”

Another reason for optimism from Supreme Cannabis is its recent close on the acquisition of Toronto-based and privately held Truverra for 14.7 million shares of Supreme Cannabis’ common stock. Truverra will operate as a wholly owned subsidiary of Supreme Cannabis (http://ibn.fm/XCvVV).

The purchase intensifies the focus by Supreme Cannabis on expanding its cannabis presence in Europe. A subsidiary of Truverra is Netherlands-based Truverra Europe, which sells hemp-based CBD products in select European markets (http://ibn.fm/HoXOj).

The Supreme Cannabis portfolio includes 7ACRES, an award-winning brand; Cambium Plant Sciences, a cultivation IP and plant genetics company; Medigrow Lesotho, a South African cannabis oil producer; Supreme Heights, an investment platform focused on CBD; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Geyser Brands continues to strengthen its leadership team with industry leaders
• The company’s proprietary nanotechnology formulations transport therapeutic agents with superior bioavailability and efficacy
• Geyser Brands is pursuing the acquisition of Solace Management Group, solidifying its place as a leading provider of health-focused CBD and hemp products

Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company, builds and markets some of the world’s leading cannabis products and brands. As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://ibn.fm/SFy2J).

One of Geyser’s wholly owned subsidiaries, Apothecary Botanicals, recently received a standard processing license from Health Canada. Receipt of the license was heralded by Geyser CEO Andreas Thatcher as “a huge milestone” for the company.

“The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,” Thatcher stated in a news release (http://ibn.fm/eKxTj). “It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.”

The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its R&D and sales licenses. Physical modifications to the Apothecary Botanicals manufacturing facility to deliver GMP-compliant capacity are complete, with production of in-house formulated branded products expected to begin sometime in late summer.

With the completion of its proposed Solace Management Group acquisition, Geyser intends to increase its production capacity with another GMP facility dedicated to hemp-related human and pet products. These products already feature the proprietary nanotechnology for stronger, more stable offerings. The intention is to extend the Solace product and formulations into the regulated cannabis space through Geyser’s licensed producer.

Adding strength to the company’s endeavors is the recent addition of several seasoned industry leaders to its management team (http://ibn.fm/In1BX). Joining the board of directors is Dr. Bin Huang, a seasoned life sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia.

Chartered Professional Accountant Gordon Clissold, who has over 20 years of experience as an operational and financial manager for both public and private companies, has been named chief financial officer. Clissold has also served as a past president of the Certified General Accountants of BC. These pivotal appointments to Geyser Brands’ leadership team are expected to bring valuable oversight and experience to the company as it pursues strategic goals in 2019 and beyond.

In combination with its proposed acquisition of Solace Management Group, these additions are expected to play a key role in establishing Geyser Brands as a leading provider of health-focused CBD and hemp products (http://ibn.fm/jvaX5).

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR

• VPR Brands focuses on high-quality cannabis and nicotine products that build brand loyalty
• The company boasts a portfolio of innovative brands, including its flagship HoneyStick
• VPR Brands recently sponsored the ‘Complete Voters’ Guide to 2020 US Presidential Candidates on Cannabis Issues’

A technology holding company, VPR Brands LP (OTC: VPRB) is focused on growing its brand presence in the cannabis industry by pioneering innovative products that garner customer loyalty. The company has a vested interest in supporting the cannabis industry and recently took the initiative to sponsor a comprehensive examination of presidential candidates’ stances on cannabis policies. This study is the first of its kind and signifies VPR Brands’ leadership in the ever-evolving cannabis industry.

With its innovative brands, VPR Brands achieved 2018 revenue of $4.6 million, marking a 28 percent year-over-year increase (http://ibn.fm/z5bTG). Moreover, for Q1 2019, the company increased its quarterly revenues roughly 31 percent year-over-year to $1.3 million. VPR Brands also continues to maintain strong gross operating margins above 40 percent (http://ibn.fm/qEddF).

VPR Brands is innovating in the vaping marketplace by focusing on high-performance, high-quality products that build brand loyalty. HoneyStick, an upper-tier vaporizer, is the company’s flagship brand. VPR Brands has also entered the CBD market with its GoldLine CBD product line. The company’s Helium, Krave, Vaporin, and VaporX products are ancillary brands serving the nicotine vertical. In addition, VPR engages in product development for the vapor or vaping market, including e-liquids.

Recently, VPR Brands launched its HRB Turbo Dry Herb Vaporizer by HoneyStick (http://ibn.fm/j1E2p). This ultra-premium, pocket-sized dry-herb vaporizer is available for an affordable $99.

“The HRB Turbo is the best dry-herb vaporizer with an MSRP under $100 currently on the market,” VPR Brands COO Dan Hoff stated in a news release. The company focuses on brand awareness and first-rate product design and formulation to meet consumer taste and expectations (http://ibn.fm/DPe3R). VPR Brands also partners with leading global brands to advance and accelerate their products into the vanguard of its industry.

Looking ahead, VPR Brands expects positive impact from recent Louisiana legislation regarding medical marijuana products. Officials from the Louisiana Department of Agriculture and Forestry announced that medical marijuana products could soon be available in licensed dispensaries. This represents a significant opportunity for VPR Brands. Patients and dispensary owners have been waiting for this development since 2015, when voters approved a measure to legalize medical cannabis.

These legalization matters will play a part in the 2020 U.S. presidential election as consumers voice their opinions. With that key issue in mind, VPR Brands sponsored (http://ibn.fm/TAp7C) ‘A Complete Voters’ Guide to 2020 US Presidential Candidates on Cannabis Issues’. In the guide’s foreword, VPR Brands CEO Kevin Frija noted that “my purpose is to support the growth of the cannabis industry and to provide clear, factual data to cannabis voters.”

“The gap between federal and state law has reached crisis level, and American businesses that could expand overnight are constrained by capital because banks risk losing their national charters should they abet the sale of what is still classified as a Schedule 1 narcotic,” continued Frija. “This inconsistent legislative patchwork affects both recreational and medical users.”

With this sponsored report, VPR Brands is focusing on a single public policy issue: cannabis. The purpose of the guide is to help voters identify where candidates stand on making cannabis legal and allowing the sector to flourish as a legitimate industry.

VPR Brands continues to advance its own dedication to growth through an experienced management team that’s committed to unique brands and expanded distribution into the CBD vertical. The company offers investors potential returns as it leverages opportunity in the nicotine and cannabis industries. VPR Brands is positioned to build market share and drive scale across different high-growth verticals.

VPR Brands owns issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components. The company cultivates brands through direct sales and licensing opportunities in the CBD (cannabidiol) vertical. With its fulfillment center and headquarters in Fort Lauderdale, Florida, VPR Brands includes the GoldLine, GoldLine Hemp, HoneyStick, Helium, Krave, Vaporin and VaporX names (http://ibn.fm/ZygTX).

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• The Green Organic Dutchman has applied for listing of its common shares on the Nasdaq
• The company announced quarterly and half-yearly financial and operational results for the periods ended June 30, 2019
• Progress of its construction efforts at two sites was included on a list of corporate highlights

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) recently announced that it has applied for a listing of its common shares on the Nasdaq. The listing will require numerous regulatory moves on the part of the company, including registration of the common shares and a confirmation by the Nasdaq that TGOD has met all applicable listing requirements.

“This is an important step in the growth of TGOD, one that will broaden our investor base and increase access for international investors as we build the leading global organic cannabis brand,” TGOD CEO Brian Athaide stated in a news release (http://ibn.fm/JX1Ky). “Our team remains focused on executing our business plan and creating value for our shareholders.”

In addition to its Nasdaq application, TGOD announced its financial and operational results for the period ended June 30, 2019 (http://ibn.fm/9IIRc). “Q2 was pivotal for the company as we began commercial production in the second phase of our Hamilton site and expanded our product line for the Grower’s Circle,” Athaide continued.

Highlights of the company’s operations and performance during the quarter included the following:

• Construction of the company’s Hamilton site and phase 1 at its Valleyfield site are nearing completion. The investment value reached $53.1 million in the second quarter of 2019, with total investments for the year amounting to $100.9 million.
• TGOD achieved a revenue increase of 20 percent over the prior quarter, with revenues amounting to $2.9 million and stemming primarily from the European markets. The company reported a net loss of $16.6 million for Q2 2019 but continues to maintain fiscally responsible practices.
• The company launched its Grower’s Circle project in Canada, which is currently testing the company’s sales and distribution capabilities.

Athaide commented on his team’s commitment to executing its “ambitious” business plan, realizing double digit quarterly growth in Europe and nearing the end of its construction project in Canada. “The product quality feedback from Grower’s Circle has been overwhelmingly positive, confirming that patients appreciate having access to premium certified organic cannabis, an underserved segment of the market,” Athaide added (http://ibn.fm/rjzBY). “We now have our first purchase order from the OCS in hand and look forward to shipping our first recreational sales this week.”

The Green Organic Dutchman produces organic, pesticide-free cannabis using crafting techniques in farming. The company envisions becoming a global leader in providing premium-quality cannabis products that improve the lives of its customers. The company currently conducts operations in the medical cannabis markets of Canada, Europe, the Caribbean and Latin America.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• ETST outlined a multiple-year goal of growing a market for its pure, natural extracted products in the CBD space
• The company creates proprietary CBD products that are unique to the nutraceuticals industry
• Its cutting-edge technology, including its super-critical extraction process, is designed to create pure and natural hemp oil

Earth Science Tech Inc. (OTCQB: ETST) outlined a five-year plan in its July 10-K annual report filed with the SEC. The report details a strategy of creating ETST’s proprietary line of CBD hemp extracts through a gentle and natural process that utilizes a super-critical extraction process using CO2 compression, isolation and micron filtration (http://ibn.fm/H330b).

The result is high-grade, CBD-rich hemp oil and other CBD products that have additional natural molecules. ETST’s highly technical extraction process creates pure, easily digested, rich CBD hemp oil that’s unique to the nutraceuticals industry. ETST plans to scale-up its processing capability to accommodate new products in its pipeline, per the report, and it aims to make its innovative hemp products available worldwide.

The report also explained that hemp-based CBD is one of at least 80 cannabinoids found in hemp and is non-psychoactive.

ETST’s U.S.-based operation oversees its supply chain, including raw material processing, product development and manufacturing, and sales and marketing. ETST plans to continue expanding its line of supplements and proprietary CBD-rich hemp oil to broad and diverse channels, including online, pharmacies, clinics and in-store sales.

ETST is currently sourcing its CBD-rich hemp oil from high-quality industrial hemp plants grown in Oregon and Kentucky. Referencing its product’s cultivation, ETST maintains that its CBD-rich hemp oil is “sourced from the high quality industrial hemp plants grown by generational family farmers,” and that, throughout the process, the product is lab tested several times “from seed to shelf” for “cannabinoid panel content, terpenoids, pesticides, residual solvents, mycotoxins and micros.” This attention to detail in production quality is a valuable hallmark of ETST’s success, differentiating it from its competitors.

“We believe that our formulations will set us apart from competing products for promoting health,” the company stated in the SEC filing. “We have formulated and produced our initial CBD products, intended for subject to performance treating various symptoms of diseases and ailments or for overall health. The company plans to expand manufacturing and marketing of these CBD products with expansion of products over the next five years.”

ETST is a biotech company focused on the nutraceutical and pharmaceutical fields. It performs R&D on cannabis and industrial hemp, markets a line of cannabis products, and maintains a portfolio of diverse subsidiaries.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Petroteq Energy’s proprietary Clean Oil Recovery Technology (CORT) can extract up to 99 percent of crude oil and produces no waste or greenhouse emissions
• CORT licensing is seen as a future line of growth for Petroteq
• The company announced that it has received positive lab results regarding the recovery of oil from international ore samples
• The company recently sealed a major licensing agreement with Texas energy company Valkor

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is revolutionizing the heavy oil recovery process through its clean, closed-loop technology that’s capable of extracting fuel from sands and returning the cleaned sands back to the earth.

The proprietary mechanism is called Clean Oil Recovery Technology (CORT). The technology was developed for surface tar-sand extraction, and it is suitable for all hydrocarbon deposits. The patented 14-stage process can extract up to 99 percent of crude oil and recycle over 99 percent of the solvent used in the process. CORT can also be deployed for land remediation projects, either independently or integrated with other processes.

Several key advantages define the superiority of the CORT approach. The technology does not require any water; it does not emit greenhouse gas; and it does not require high temperatures. Additionally, the process leaves virtually no waste; the only product returned back after the completion of the extraction is clean sand.

An August 19, 2019, press release announced that the company has received positive lab results on the recovery of oil from international ore samples. Stage 1 laboratory testing with the oil sands samples provided by a separate Asian energy firm using Petroteq’s CORT on oil sands samples was completed on August 15, 2019. The testing was undertaken to determine the geophysical characteristics of the oil and demonstrated that Petroteq’s proprietary technology was able to recover a maximum oil content of approximately 20 percent saturation, with results approaching greater than 90 percent yield of heavy oil from the supplied surface minable heavy oil project samples.

In addition, Petroteq reported results from its stage 2 laboratory testing with oil shale samples provided by Queensland Energy Mining Limited (“QEM”) using Petroteq’s CORT on previously drilled QEM core samples. The preliminary stage 2 QEM test results demonstrated that Petroteq’s proprietary technology was able to recover up to 65 percent of the contained oil from Julia Creek project samples.

Petroteq is making the technology available to other organizations in the field, as well. On July 2, 2019, the company announced its entry into a non-exclusive technology licensing agreement with Valkor LLC, an eastern Texas energy services company (http://ibn.fm/re0Zh). This licensing agreement for Petroteq’s CORT grants Valkor non-exclusive rights to the use of the patented extraction solution.

This is the first licensing agreement that demonstrates the potential of CORT. Petroteq currently envisions opportunities to license the extraction technology in more than 20 countries that have oil sand resources.

CORT roll-out discussions are ongoing in parts of the world like Canada, the Middle East, Africa and South America. The proprietary nature of the technology, its enhanced extraction capabilities and its remediation opportunities give Petroteq significant growth potential upon which it intends to capitalize in the future.

“The licensing model is an important component of the Petroteq business model allowing Petroteq to leverage its proprietary technologies and operating techniques to participate in value created through investment by other companies and strategic investors,” an official corporate announcement reads.

According to Valkor CEO Steve Byle, prior cooperation with Petroteq shows that the CORT platform is unique and highly effective. It is a great match to Valkor’s long-term strategy, Byle concluded in a news release.

Petroteq Energy is a Canadian-registered publicly traded company that focuses on the development and implementation of proprietary solutions for the sustainable extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits.

The company has currently concentrated its oil sand exploration and production efforts on Utah and, more specifically, its Asphalt Ridge project. The Asphalt Ridge mineral lease spans 2,500-plus acres and features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent.

For more information, visit the company’s website at www.Petroteq.energy

NOTE TO INVESTORS: The latest news and updates relating to PQEFF are available in the company’s newsroom at http://ibn.fm/PQEFF

• SING president reports that the company’s solar division is growing in residential markets and expanding into commercial markets
• In the industrial hemp and CBD sector, SING is debuting a lotion product, expanding TorusMed and adding a water-soluble tincture product
• SING was named as the master distributor for the Pure Hemp line of American-grown hemp cigarettes

SinglePoint Inc. (OTCQB: SING) President Wil Ralston said on MoneyTV that SING is growing in several directions. During an interview with host Donald Baillargeon (http://ibn.fm/K0SZW), Ralston projected that the company’s solar division will generate some $5 million in revenues this year as it continues to increase residential sales and adds commercial sales while also providing funding options for small to medium businesses on renewable projects.

During the interview, Ralston predicted that, for SING’s year ended December 31, 2019, solar would generate an estimated $5 million in revenues. “There’s just so much going on in the renewables space that we’re able to tap into, especially through the Direct Solar Capital arm, because not only are we funding solar projects, but we can also fund back-up batteries, natural gas, anything within the renewables space,” Ralston said in the interview.

Direct Solar of America, a subsidiary of SinglePoint, has added Direct Solar Capital as an alternative-energy financial solution that’s able to finance capital-ready solar projects in amounts ranging from $50,000 to $3 million.

On MoneyTV, Ralston also discussed the company’s focus on its CBD business. SinglePoint is expanding its product line and has introduced new products, including a lotion product from TorusMed, he said. TorusMed has been one of the company’s strongest sellers, and its exposure has been expanded to chiropractic clinics, massage therapists and similar outlets.

Ralston noted that he is also excited about the company’s new unflavored, water-soluble tincture product that can be added to any type of beverage. It can also be rubbed right onto the skin, because it is not oily, Ralston noted.

Ralston also discussed SING’s status as a master distributor for the Pure Hemp line of American-grown hemp cigarettes. SING has already attended three trade shows as part of its due diligence process, scouting out demand for the product. Ralston said that he believes there is great opportunity in the hemp cigarette space (http://ibn.fm/c2yYo).

“Not long ago, SinglePoint made a significant commitment to be a major provider in the industrial hemp space,” Ralston observed. “And the agreement with Pure Products is another bold move for the company to solidify our place in the industry.”

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• Lexaria recently announced its entry into a partnership with a tobacco giant to fund the research and development of oral nicotine delivery solutions
• The company received a cannabis R&D license from Health Canada
• LXRP also announced its receipt of four new patents and its launch of ChrgD+

Many consumers don’t realize that they don’t need to smoke to partake of nicotine. In fact, new advancements are providing an alternative to the risks associated with smoking, which were first officially revealed by a damning surgeon general report in 1963 linking smoking to lung cancer, emphysema and heart disease. Case in point, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed technology that offers an alternative method of nicotine ingestion that is safer than smoking, and the company hopes to change the world for the better by eliminating the diseases caused by combusting tobacco.

The technology, known as DehydraTECH, is a patented, cost-effective delivery mechanism that has been shown to improve the ingestibility of cannabinoids, vitamins, nonsteroid anti-inflammatory drugs (NSAIDs) and nicotine. Now, Lexaria has partnered with one of the world’s largest tobacco firms to develop new, reduced-risk, oral nicotine products using the technology (http://ibn.fm/pddAe).

The deal funds Lexaria’s R&D program – and consumer product development – in exchange for certain DehydraTECH license rights and a minority equity interest in Lexaria Nicotine, a wholly owned subsidiary of Lexaria Bioscience Corp. An initial tranche of $1 million has been provided, with additional phases providing up to $12 million total. Lexaria has granted a license for its technology to be used in nicotine-based oral-format products on an exclusive basis in the United States and a nonexclusive basis elsewhere globally, for which it will receive royalties on every dollar of revenue generated utilizing its technology.

The strength of the relationship is evident from the recent appointment of Brian Quigley to the Lexaria board of directors. Most recently, Quigley spent 16 years at the tobacco giant, with seven of those years as president and CEO of a major business unit. He is a 20-year veteran of the consumer packaged-goods industry and has managed complex regulatory environments, including those for nicotine products (http://ibn.fm/j4mMb).

Lexaria also recently announced that it had been issued a cannabis R&D license by Health Canada, with a four-year term extending to August 9, 2023 (http://ibn.fm/2IzvQ). The new license will allow one of the country’s newest and most-advanced laboratories to conduct extensive investigatory work in both THC and CBD delivery using proprietary, optimized formulations and techniques. The laboratory was purpose built, is permitted at local and federal levels, and is fully outfitted with equipment required to produce DehydraTECH infusions, including two different methodologies of creating nano-sized molecules.

The Health Canada license came at an opportune time. Lexaria recently announced the receipt of four new patents (http://ibn.fm/spv68), bringing the company’s issued patent total to 15 (eight in the United States and seven in Australia), with roughly 60 patent applications still pending throughout the world. The granted patents cover delivery of cannabinoids such as THC and CBD; NSAIDs such as ibuprofen; nicotine; and a range of vitamins.

The DehydraTECH technology has already been deployed with the launch of ChrgD+, a water-soluble, ready-mix hemp supplement powder that can be added to a variety of beverages, hot or cold (http://ibn.fm/nQKUS). At just two grams per pouch, ChrgD+ packets can be carried discreetly in a shirt pocket or purse and consumed anywhere in a soft drink, coffee or other beverage. ChrgD+ is nearly flavorless and odorless and offers minimal impact to taste; users experience a delightful food-grade pearlescent sparkle effect to remind them that they are getting its benefits.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP